Navigation Links
Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO™ data Presented at the European Atherosclerosis Society 2012 Meeting
Date:5/23/2012

CARLSBAD, Calif., May 23 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announces the following webcast:What:Data from KYNAMRO™ presented at EAS 2012When:Friday, June 1st at 12:00 p.m. ET / 9:00 a.m. PTWhere:www.isispharm.comHow:Live on the Internet.  Simply log onto our Web site listed above. If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.


'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series
2. Delcath to Webcast Managements Presentation at Annual Meeting of Stockholders
3. Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
4. Ampio Pharmaceuticals Schedules 2012 Update Webcast
5. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
6. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
7. Heartware Schedules First Quarter Conference Call And Webcast
8. Cempra, Inc. to Report First Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on May 10, 2012
9. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015 /CNW Telbec/ - Ergoresearch Ltd ... and known under the « Équilibre, orthèses ... the transaction previously announced on April 23, 2015 regarding ...  shares of Orthoconcept (2008) inc.   The ... shares (TSXV: ERG) to the vending shareholder, namely 9211-5096 ...
(Date:5/5/2015)... Valley Medical Center, named a Top 100 Hospitals® in the ... to deploy the wireless Leaf Patient Monitoring System in its ... labor and risk of caesarian births. Studies show ... is reduced in mothers who are upright and mobile during ... epidurals and tend to lie in their labor room beds. ...
(Date:5/5/2015)... , May 5, 2015  IQPC,s 19 th ... announce the chairman of the Summit Mr. Phani Bidarahalli ... will be joined by the expert speaker faculty including senior ... May 11 – 12, at The Hotel Kabuki in ... is available for download on the event website, which can ...
Breaking Medicine Technology:Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2
... 17, 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... Animal Health, Inc., a developer of DNA-based vaccines and ... T cell responses from VAH-5000D, its DNA vaccine encoding ... with cancer. This preclinical data was presented by Dr. ...
... Terumo Cardiovascular Systems (Terumo CVS) announced today that ... a Class I action the company,s recent voluntary recall ... instances of adhesive build-up and/or skiving of plastic (plastic ... defect was discovered during in-house inspection after Terumo CVS ...
Cached Medicine Technology:VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 2VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 3VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 4FDA Classifies Recent Terumo CVS Recall of Coronary Ostia Cannulae as Class I Action 2
(Date:5/5/2015)... 2015 Leveraging the industry-leading technology found ... an experienced team of fertility specialists are committed to ... around the globe. , “We’re honored that Maternity Health ... a global leader in reproductive medicine. The clinic offers ... in the world who play an important role in ...
(Date:5/5/2015)... global lab automation market is expected to reach $5,105.7 ... an estimated CAGR of 6.7% from 2015 to 2020. ... basis of equipment and software, application, type of automation, ... Lab Automation Market is classified into clinical diagnostics, drug ... a major application of the lab automation market. Developing ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... ) filed on behalf of men who ... their use of prescription testosterone replacement therapies ... multidistrict litigation underway in U.S. District Court, ... documents dated May 1st, defendants AbbVie, Inc., ...
(Date:5/5/2015)... Viverae®, a health management and ... leading multinational developer, manufacturer and marketer of innovative, ... urology, oncology and surgical specialty products, as the ... Vanguard Award recognizes outstanding achievement in the design ... significant client base. , Viverae reviewed the employee ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Baptist Medical ... Commission on Cancer (CoC) of the American College of ... program must meet more than 30 Commission on Cancer ... a survey process, and maintain levels of excellence in ... When patients choose to seek care locally at a ...
Breaking Medicine News(10 mins):Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4
... (PSA) testing continues to be problematic. Even though it ... death, illness or disability from prostate cancer, testing has ... recent nation-wide survey indicates almost half of Canadian men ... In this review, Drs. Ian Thompson and Donna Ankerst ...
... it, and now a scientific study has backed them up ... teens feel older than they really are. Researchers at the ... at the University of Victoria, carried out the study. ... random sample of nearly 700 adolescents between 12 to 19 ...
... designed backpacks have come as a boon for cancer patients ... Like in the case of Nick Gall-Tomassen, aged 31, ... time away from the ward. ,His backpack holds ... vein in his arm. Nick says this has given him ...
... Breast cancer specialists from Princess Margaret Hospital (PMH) ... procedure, called intraoperative radiation therapy , takes less than ... treatments. ,The PMH team combined the expertise ... therapists) and nurses to perform its first procedure. It ...
... to a study published online ahead of print in the ... are less likely to develop an involuntary eye spasm called ... and can leave them effectively blind. ,The effect ... to two cups per day were needed for the protective ...
... colleagues identify the key signaling molecules that regulate epithelial ... a combination of mouse mutant analyses , organ culture ... limited capacity to regenerate teeth, mouse incisors contain stem ... researchers show that signals from the adjacent mesenchymal tissue ...
Cached Medicine News:Health News:Dating, Drugs and Sex Make Teens Feel Older Than They are 2Health News:Special Backpacks Provide Much Needed Relief for Cancer Patients 2Health News:Interoperative Radiotherapy for Breast Cancer Patients 2Health News:Eyelid Spasm can Be Prevented by Coffee Drinking 2
Inorganic phosphorus reagent is used for the quantitative determination of inorganic phosphorus in human serum....
Amylase (EPS-G7, kinetics), Wavelength: 405 nm. Linear range; 5-1500 IU/L....
Intended for the quantitative determination of alphaamylase activity in serum. Single vial, dry powder reagent. Reaction: Kinetic. Wavelength: 405 nm. Linearity: 2000 U/L at 37C....
For the direct, colorimetric determination of calcium in human serum or urine. Linearity: 20 mg/dl....
Medicine Products: